UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053276
Receipt number R000060809
Scientific Title Safety of long-term consumption of Tablets.
Date of disclosure of the study information 2024/01/08
Last modified on 2024/03/14 19:09:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety of long-term consumption of Tablets.

Acronym

Safety of long-term consumption of Tablets.

Scientific Title

Safety of long-term consumption of Tablets.

Scientific Title:Acronym

Safety of long-term consumption of Tablets.

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the safety of consumption of Tablets of recommended daily intake for 12 weeks on healthy adult males and females.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Hematologic test, Blood biochemistry test, Urine test, Blood pressure/pulsation, Weight/body mass index, Medical Interview, before and 4, 8,12 weeks after intake and Adverse events thorough the study

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Consumption of Tablets, quantity of recommended daily intake, for 12 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy males and females from 20 to 64 years of age

Key exclusion criteria

(1) Subjects who are taking healthy foods related functional substance for at least one day a week at the start of this study
(2) Subjects who have abnormalities in clinical examination values, cardiopulmonary function, or have a history of serious kidney or gastrointestinal diseases
(3) Subjects who may develop allergies in relation to this study
(4) Subjects who have a disease that requires constant medication (whether external or internal), those who have a disease under treatment (except for dry eye and dental caries treatment), those who have a history of serious disease that required medication
(5) Subjects whose physical measurements, physical examination values, and clinical examination values before the start of intake were significantly out of the reference range
(6) Subjects who work in shifts, work late at night, or have an irregular daily rhythm
(7) Subjects who are participating in the other study within 1 month before the start of this study
(8) Subjects who plan to become pregnant or breastfeed during the study period
(9) Subjects who are judged to be unsuitable as subjects based on the answers to the background survey
(10) Subjects who are judged as unsuitable for the study by the investigator for other reason

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Ueno

Organization

MEGMILK SNOW BRAND Co.,Ltd.

Division name

Milk Science Research Institute

Zip code

350-1165

Address

1-1-2 Minamidai, Kawagoe, Saitama

TEL

049-242-8165

Email

hiroshi-ueno@meg-snow.com


Public contact

Name of contact person

1st name Saki
Middle name
Last name Miyayama

Organization

EP Mediate Co., Ltd.

Division name

R&D Support Center Foods Department

Zip code

162-0821

Address

Kagurazaka AK Bldg., 1-8 Tsukudocho, Shinjuku-ku, Tokyo

TEL

070-3023-8210

Homepage URL


Email

miyayama.saki392@eps.co.jp


Sponsor or person

Institute

EP Mediate Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

MEGMILK SNOW BRAND Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Station Clinic Research Ethics Committee

Address

3-12-8, Takaban, Meguro-ku, Tokyo

Tel

03-6452-2712

Email

nakagawa.akiko297@eps.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

社会福祉法人新栄会 滝野川病院(東京都)


Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 12 Month 14 Day

Date of IRB

2023 Year 12 Month 14 Day

Anticipated trial start date

2024 Year 01 Month 09 Day

Last follow-up date

2024 Year 05 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 05 Day

Last modified on

2024 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060809


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name